Neil Woodford in the game to buy back his former unlisted portfolio that's proving hard to sell — reports
As brokers struggle to offload the portfolio of assets formerly managed by Neil Woodford, an unlikely buyer has emerged.
The disgraced stockpicker is reportedly gauging investor interest in a comeback bid to reacquire some of those unlisted company stakes, including equity in drug discovery startup BenevolentAI and TCR player Immunocore.
If he manages to pull enough funding — £500 million (close to $720 million) would be required — Woodford would set up a new vehicle to buy back his darlings at a discount. The target audience will be professional, sophisticated backers rather than retail investors.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.